# Evaluation of the Role of Neurodegeneration in Schizophrenia

> **NCT05257720** · — · COMPLETED · sponsor: **Istanbul Saglik Bilimleri University** · enrollment: 178 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DIAGNOSTIC_TEST:** GFAP, S100B

## Key facts

- **NCT ID:** NCT05257720
- **Lead sponsor:** Istanbul Saglik Bilimleri University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-28
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257720, "Evaluation of the Role of Neurodegeneration in Schizophrenia". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05257720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*